Ubrelvy

Ubrelvy (ubrogepant) is used to treat migraine headaches. Uberlvy is a CGRP receptor antagonist, which works by blocking a protein that is released during migraine attacks. The most common form of Ubrelvy is a 50mg tablet. It is also available as a 100mg tablet. There are currently no generic alternatives for Ubrelvy. It is covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost.

With the Patient Assistance Program from AbbVie, you can receive up to 12 months of medication at no cost to you if you are approved. You can also reapply as needed.